Discover GeneDx’s Q3 2025 earnings highlights: record revenue growth, increased guidance, FDA validations, and expansion in precision medicine.

Natera (NTRA) just shared phase 3 trial results showing its Signatera test can improve both disease-free and overall survival for muscle-invasive bladder cancer patients. These findings position ...

Australia’s financial regulator, ASIC, confirmed that Cboe Global Markets has decided to sell its Australian and Canadian market operations as part of a ...

The latest data suggest that the U.S. economy is entering a new phase of automation — one that targets brainpower rather than ...

A starter job can pay you well enough for now. Check out our list of remote entry-level jobs that pay at least 60k to see if ...

A crypto whale deposited $3M USDC on HyperLiquid to short $1.4M in Zcash, sparking debate over market correction risks and whale-driven volatility.

E-commerce florist and gift retailer 1-800-FLOWERS (NASDAQ:FLWS) missed Wall Street’s revenue expectations in Q3 CY2025, with ...

Onto their daily workflows: Surveys find that half of all consulting firms use AI in at least one business area. AI is no ...

Online therapy provider Talkspace reported another strong quarter with 25% revenue growth, driven by its expanding payer ...

In a market often driven by fleeting hype, a few digital assets are separating themselves through strategy, execution, and ...

Viasat faces a high-risk, binary event with the upcoming ViaSat-3 F2 satellite launch in early November. Click here to read ...